Drug recall D-1413-2020
Product
Lisinopril Tablets USP, 10 mg, 1000 count bottles, Manufactured by: Lupin Limited, Nagpur INDIA, For BluePoint Laboratories NDC 68001-334-08
Reason for recall
Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg
Lots and codes
Lot # Q000232, exp. date 01/2022
Recall details
- Recalling firm
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Quantity
- 11,688 bottles
- Distribution
- Product was distributed to OH and may have been further distributed throughout the United States.
- Type
- Voluntary: Firm initiated
- Recall initiated
- July 17, 2020
- Terminated
- August 26, 2021
Related products
- Lisinopril – drug information
- NDC 68001-333 Lisinopril · Lisinopril 5 mg/1 · BluePoint Laboratories
- NDC 68001-332 Lisinopril · Lisinopril 2.5 mg/1 · BluePoint Laboratories
- NDC 68001-486 Lisinopril · Lisinopril 40 mg/1 · BluePoint Laboratories
- NDC 68001-334 Lisinopril · Lisinopril 10 mg/1 · BluePoint Laboratories
- NDC 68001-336 Lisinopril · Lisinopril 30 mg/1 · BluePoint Laboratories
- NDC 68001-335 Lisinopril · Lisinopril 20 mg/1 · BluePoint Laboratories